RZLT - Wall Street Estimates - Rezolute, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 4.87

2.31 %

$ 282 M

Market Cap

-3.83

P/E

Price Target Average

177.21%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

18.92%

Net Income Estimate

39.58%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Rezolute, Inc.

Wall Street analysts predict an average 1-year price target for RZLT of $13.5 , with forecasts ranging from a low of $11 to a high of $15 .

RZLT Lowest Price Target Wall Street Target

11 USD 125.87%

RZLT Average Price Target Wall Street Target

13.5 USD 177.21%

RZLT Highest Price Target Wall Street Target

15 USD 208.01%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free